Based on recent data, Aldeyra Therapeutics, Inc. (ALDX) shows an Average True Range (ATR) of 0.38 and an Enterprise Value of 104.88M. Its average trading volume over the past 3 months is 1.02M, indicating liquidity. These fundamental metrics provide insight into ALDX's underlying financial health and market activity.
| ATR | 0.38 |
| Enterprise Value | 104.88M |
| Avg Vol (3 Months) | 1.02M |
| Avg Vol (10 Days) | 694.12K |
Aldeyra Therapeutics, Inc. (ALDX) technical indicators as of February 7, 2026: the SMA 20 is 11.31%, SMA 50 at 12.21%, and SMA 200 at 21.98%. The RSI 14 value is 61.12, suggesting its current momentum. These technical analysis signals help assess ALDX's price trends and potential future movements.
| SMA 20 | 11.31% |
| SMA 50 | 12.21% |
| SMA 200 | 21.98% |
| RSI 14 | 61.12 |
Aldeyra Therapeutics, Inc. (ALDX) stock performance overview as of February 7, 2026: The 52-week high is $7.2 (currently -23.19% below), and the 52-week low is $1.18 (currently 385.09% above). Over the past year, ALDX's performance is -0.63%, compared to the S&P 500's 8.57% change.
| 52-Week High | 7.2 |
| 52-Week High Chg | -23.19% |
| 52-Week Low | 1.18 |
| 52-Week Low Chg | +385.09% |
| S&P 500 52-Week Chg | 8.57% |
According to market data, Aldeyra Therapeutics, Inc. (ALDX) stock's recent performance metrics show that over the last month, ALDX is -9.52%, with a Year-to-Date (YTD) performance of -8.3%. Over the past year, the stock has seen a -0.63% change. These figures summarize ALDX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 5.61 | 5.93 | 5.93 | 6.18 | 7.2 | 5.93 |
| Low | 4.92 | 3.95 | 3.94 | 3.94 | 1.18 | 3.95 |
| Performance | +15.01% | -9.52% | -9.70% | -11.87% | -0.63% | -8.30% |
According to current financial data, ALDX stock's P/E (TTM) ratio is -7.75, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ALDX, including P/S (N/A), P/B (6.80), and P/FCF (-8.35), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ALDX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -7.75 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.72 | 5.98 |
| P/B (TTM) | 6.8 | 34.99 | 9.08 | 5.47 |
| P/FCF (TTM) | -8.35 | -12.34 | -200.6 | 32.07 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep